Read + Share
Liu SM, Tu HY, Wei XW, Yan HH, et al. First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a
patient-centric phase 2 trial. Nat Med 2023 Jul 24. doi: 10.1038/s41591-023-02461.
PMID: 37488286
|
 |
|
Liu SM, Tu HY, Wei XW, Yan HH, et al. First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a
patient-centric phase 2 trial. Nat Med 2023 Jul 24. doi: 10.1038/s41591-023-02461.
PMID: 37488286
|
|
|
|